Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

146.93 -0.35 (-0.24%)

Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	359,655
Open	148.17
Bid (Size)	133.33 (100)
Ask (Size)	150.20 (100)
Prev. Close	147.28
Today's Range	146.53 - 148.38
52wk Range	84.23 - 160.18
Shares Outstanding	99,700,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Neurocrine Biosciences Inc (NASDAQ:NBIX) Offers a Prime Example of Growth at a Reasonable Price ↗

December 16, 2025

Neurocrine Biosciences exemplifies GARP investing, blending strong earnings growth, solid profitability, and a reasonable stock price within its sector.

Via Chartmill

Neurocrine Biosciences Inc (NASDAQ:NBIX) Combines Strong Fundamentals with Bullish Technical Setup ↗

December 04, 2025

Neurocrine Biosciences (NBIX) combines strong growth, high profitability, and a positive technical breakout setup in the neuroscience sector.

Via Chartmill

Performance

YTD	+6.6%	+6.6%
1 Month	+4.0%	+4.0%
3 Month	+0.4%	+0.4%
6 Month	+14.6%	+14.6%
1 Year	+7.3%	+7.3%

More News

Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗

December 03, 2025

Via The Motley Fool

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗

December 03, 2025

Via The Motley Fool

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗

December 03, 2025

Via The Motley Fool

Neurocrine (NBIX) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗

November 26, 2025

Via Investor's Business Daily

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗

November 18, 2025

Via The Motley Fool

Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗

November 18, 2025

Via The Motley Fool

High Growth Momentum Stock NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Shows Strong Earnings Acceleration ↗

November 13, 2025

Via Chartmill

Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile ↗

November 11, 2025

Via Benzinga

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 11, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX) Fits the Affordable Growth Profile ↗

November 05, 2025

Via Chartmill

Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents a Compelling Value Investment Case ↗

October 30, 2025

Via Chartmill

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Q3 2025 Earnings Top Estimates, Driving Stock Momentum ↗

October 28, 2025

Via Chartmill

Neurocrine Bio Surges After Crushing Third-Quarter Expectations ↗

October 28, 2025

Via Investor's Business Daily

Examining the Future: Neurocrine Biosciences's Earnings Outlook ↗

October 27, 2025

Via Benzinga

S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗

October 29, 2025

Via Benzinga

What 13 Analyst Ratings Have To Say About Neurocrine Biosciences ↗

October 21, 2025

Via Benzinga

Demystifying Neurocrine Biosciences: Insights From 12 Analyst Reviews ↗

October 20, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents an Affordable Growth Opportunity ↗

October 15, 2025

Via Chartmill

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Presents a Compelling Growth and Breakout Opportunity ↗

October 09, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 25, 2025

Via Benzinga

Neurocrine Biosciences Inc (NASDAQ:NBIX): An Affordable Growth Candidate in Biotechnology ↗

September 23, 2025

Via Chartmill

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?

Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?

Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?

The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market

What is the current price of Neurocrine Biosciences, Inc. - Common Stock?

The current price of Neurocrine Biosciences, Inc. - Common Stock is 146.93

When was Neurocrine Biosciences, Inc. - Common Stock last traded?

The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 12/24/25 01:00 PM ET

What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?

The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 14.65B

How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?

Neurocrine Biosciences, Inc. - Common Stock has 15B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.